GlassScriptPhysician profile
Scott L Greenberg
NPI 1083632293
$29,220.72
in general payments reported to CMS, 2019-2025
26 companies · $639 in 2025
The $639 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $1,729 · 2021: $2,007 · 2022: $3,693 · 2023: $1,095 · 2024: $999 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,733.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $19,856.35 | 2019-2020 | |
| Medtronic, INC. | $4,848.42 | 2021-2025 | Flexcath Advance, Micra, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $1,153.57 | 2019-2025 | Farapulse, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Abbott Laboratories | $909.48 | 2019-2025 | Confirm Rx, Tacticath Ablation Catheter, Sensor Enabled, Ensite |
| Pfizer INC. | $390.52 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $357.38 | 2019-2024 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $256.98 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $256.42 | 2022-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $169.52 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $146.92 | 2019-2024 | |
| Biosense Webster, INC. | $142.75 | 2020-2025 | Carto 3 |
| Kestra Medical Technology Services, INC. | $128.36 | 2025 | Assure Wcd |
| Regeneron Pharmaceuticals, INC. | $122.81 | 2019 | |
| Novo Nordisk INC | $93.36 | 2023 | Wegovy |
| Philips North America LLC | $84.03 | 2023-2025 | Mcot, (Ck7) Extended Holter |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $49.07 | 2021-2023 | Farxiga |
| Atricure, INC. | $49.06 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.84 | 2019 | |
| Ge Healthcare | $28.31 | 2022 | |
| Zoll Respicardia, INC. | $27.67 | 2023 | Remede System |
| Medicomp INC | $23.89 | 2024 | Telepatch Cardiac Monitor |
| Inspire Medical Systems, INC. | $23.18 | 2023 | Inspire |
| Irhythm Technologies, INC. | $21.43 | 2023 | Zio Xt Patch |
| Altathera Pharmaceuticals LLC | $16.43 | 2024 | Sotalol Hydrochloride |
| Baxter Healthcare | $14.57 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Convatec INC. | $14.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.